Infliximab as treatment of severe enteropathy in a patient with common variable immunodeficiency and cytomegalovirus infection
Gastroenterol Hepatol. 2018 Mar;41(3):163-164.
doi: 10.1016/j.gastrohep.2017.03.002.
Epub 2017 May 2.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Aparato Digestivo, Hospital Universitario de Basurto, Bilbao, Vizcaya, España. Electronic address: janire.prietoelordui@osakidetza.net.
- 2 Servicio de Aparato Digestivo, Hospital Universitario de Basurto, Bilbao, Vizcaya, España.
No abstract available
MeSH terms
-
Adult
-
Common Variable Immunodeficiency / complications*
-
Cytomegalovirus Infections / complications*
-
Female
-
Gastrointestinal Agents / therapeutic use*
-
Humans
-
Infliximab / therapeutic use*
-
Intestinal Diseases / drug therapy*
-
Intestinal Diseases / etiology*
-
Severity of Illness Index
Substances
-
Gastrointestinal Agents
-
Infliximab